Search results for "Mental disorder"

showing 10 items of 1586 documents

The Panic-Associated Symptom Scale: measuring the severity of panic disorder.

1991

The Panic-Associated Symptom Scale (PASS) is presented as a new measurement of the severity of the core symptoms of panic disorder. This first description addresses the rationale for its design and its scoring, score distributions, test-retest reliability, correlations within the PASS and with other scales, principal component structure, and response to drug therapy. Data are presented from a large study group of patients with panic disorder (n = 1168). Problems in measuring panic disorder are discussed.

AdultMalemedicine.medical_specialtyScale (ratio)PsychometricsPsychometricsTest validitybehavioral disciplines and activitiesmental disordersmedicineHumansPsychiatryReliability (statistics)Psychiatric Status Rating ScalesPanic disorderPanicmedicine.diseaseAnxiety DisordersPanichumanitiesPsychiatry and Mental healthPhobic DisordersAnxietyFemalemedicine.symptomPsychologyArousalAgoraphobiaActa psychiatrica Scandinavica
researchProduct

Interaction between gene variants of the serotonin transporter promoter region (5-HTTLPR) and catecholO-methyltransferase (COMT) in borderline person…

2008

Borderline personality disorder (BPD) is characterized by a heterogeneous symptomatology with instability in impulse control, interpersonal relationships and self-image. BPD patients display repeated self-injury, chronic suicidal tendencies and emotional dysregulation, mainly dysregulation of negative affect. In its etiology, genetic and environmental factors have been suggested. Recently, an investigation in male healthy volunteers found gene–gene effects of the catechol-O-methyl-transferase (COMT) low-activity (Met158) and the low-expression allele of the deletion/insertion (short/long or S/L, respectively) polymorphism in the serotonin transporter-linked promoter region (5-HTTLPR) on the…

AdultMalemedicine.medical_specialtySingle-nucleotide polymorphismCatechol O-MethyltransferasePolymorphism Single Nucleotidebehavioral disciplines and activitiesCellular and Molecular NeuroscienceGene FrequencyGene interactionBorderline Personality DisorderInternal medicinemental disordersGenotypemedicineHumansAllelePromoter Regions GeneticBorderline personality disorderAllelesGenetics (clinical)Serotonin transporterSerotonin Plasma Membrane Transport ProteinsGeneticsCatechol-O-methyl transferasebiologybusiness.industryMiddle Agedmedicine.diseasePsychiatry and Mental healthLogistic ModelsEndocrinology5-HTTLPRbiology.proteinFemalebusinessAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics
researchProduct

Precursors of the evoked K-complex in event-related brain potentials in stage 2 sleep.

1997

The aim of the study was to examine precursors of the evoked K-complex as manifested in event-related brain potentials (ERPs) during stage 2 sleep. ERPs to infrequent deviant tones of 1100 and 2000 Hz and immediately preceding frequent standard tones of 1000 Hz were compared between trials containing and trials not containing a K-complex (KC trials, NO KC trials, respectively) to the deviant tones. The N350 wave to the deviant tones was markedly larger during the KC than during the NO KC trials. Also the P210 wave to the 2000 Hz deviant tone showed the same phenomenon. No definite evidence was found for the mismatch negativity-like deflection during the KC trials. ERPs to the standard tones…

AdultMalemedicine.medical_specialtySleep Stagesmedicine.diagnostic_testGeneral NeuroscienceMismatch negativitySensory systemElectroencephalographyStimulus (physiology)AudiologyElectroencephalographybehavioral disciplines and activitiesElectric StimulationPositive waveEvent-related potentialmental disordersmedicineHumansFemaleNeurology (clinical)Sleep StagesPsychologyK-complexEvoked PotentialsElectroencephalography and clinical neurophysiology
researchProduct

An adaptive display for the treatment of diverse trauma PTSD victims.

2009

El trastorno de estrés postraumático (TEPT) puede desarrollarse después de la exposición a un evento aterrador. Las personas que sufren de trastorno de estrés postraumático presentan hiperactividad y evitación, y experimentan síntomas que provocan angustia y deterioro en áreas de vida significativas. Los programas de comportamiento cognitivo, incluida la terapia de exposición, son actualmente el tratamiento de elección para el TEPT. Aunque estos programas son eficaces, hay margen de mejora; La utilización de la terapia de exposición por los médicos es baja y las tasas de desgaste son altas. La aplicación de nuevas tecnologías, especialmente la realidad virtual (VR), podría ayudar a superar …

AdultMalemedicine.medical_specialtySocial PsychologyAdolescentmedicine.medical_treatmentExposure therapyPilot ProjectsVirtual realityStatistics NonparametricFight-or-flight responseLife Change EventsStress Disorders Post-TraumaticUser-Computer Interfacemental disordersmedicineHumansComputer SimulationPsychiatryApplied PsychologyAgedCommunicationPatient SelectionFlexibility (personality)CognitionGeneral MedicineMiddle AgedComputer Science ApplicationsHuman-Computer InteractionPosttraumatic stressDistressTreatment OutcomePsicologiaFemalePersonalitatPsychologyClinical psychologyCyberpsychology, behavior and social networking
researchProduct

A telemedicine platform to improve clinical parameters in paranoid schizophrenia patients: Results of a one-year randomized study

2018

Objective The study objective was to test a smartphone-based MONEO platform designed to improve the clinical condition of paranoid schizophrenia patients. Telemedicine treatment is considered to be as effective as traditional treatment in outpatient clinics. Method A total of 290 patients with paranoid schizophrenia in the symptomatic remission state were recruited to this 12-month multicenter, open-label randomized trial. A study group (n = 191) received a smartphone with the MONEO platform installed. Patients conducted cognitive training twice a week. Patients' mental state was assessed every month via teleconference. A placebo group (n = 99) received a platform with functionality limited…

AdultMalemedicine.medical_specialtyTelemedicineParanoid schizophreniaPlacebo grouplaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawOutcome Assessment Health Caremental disordersmedicineHumansOutpatient clinicsmartphone platformparanoid schizophreniaBiological PsychiatrySchizophrenia ParanoidPositive and Negative Syndrome Scaletelephone-based interventionbusiness.industrymedicine.diseaseMobile ApplicationsCognitive RemediationCognitive training030227 psychiatryPsychiatry and Mental healthMental statePhysical therapyFemaleSmartphonetelemedicinebusiness030217 neurology & neurosurgerySchizophrenia Research
researchProduct

Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients

2010

To describe the course of positive and negative symptoms during inpatient treatment and examine remission and response rates under routine clinical care conditions.Two hundred and eighty inpatients with schizophrenia (DSM-IV criteria) were assessed with the Positive and Negative Syndrome Scale (PANSS) at admission and at biweekly intervals until discharge from hospital. Remission was defined according to the symptom-severity component of the consensus criteria (Remission in Schizophrenia Working Group) as a rating of three or less in the relevant PANSS items at discharge, and response as a reduction of at least 20% in the PANSS total score from admission to discharge.The mean duration of in…

AdultMalemedicine.medical_specialtyTime FactorsAntipsychotic treatmentSeverity of Illness IndexYoung Adult03 medical and health sciences0302 clinical medicineNaturalistic observationInternal medicineOutcome Assessment Health CareSeverity of illnessmedicineHumansYoung adultPsychiatryBiological PsychiatryRetrospective StudiesPsychiatric Status Rating ScalesPositive and Negative Syndrome ScaleRetrospective cohort studyMiddle Agedmedicine.disease030227 psychiatry3. Good healthDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthSchizophreniaTime courseSchizophreniaRegression AnalysisFemalePsychology030217 neurology & neurosurgeryAntipsychotic AgentsSchizophrenia Research
researchProduct

Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood.

1996

We studied the effects of rapid-rate transcranial magnetic stimulation (rTMS) of different scalp positions on mood Ten normal volunteers rated themselves before and after rTMS on five analog scales labeled ``Tristeza99 (Sadness), ``Ansiedad99 (Anxiety), ``Alegria99 (Happiness), ``Cansancio99 (Tiredness), and ``Dolor/Malestar99 (Pain/Discomfort). rTMS was applied to the right lateral prefrontal, left prefrontal, or midline frontal cortex in trains of 5 seconds9 duration at 10 Hz and 110% of the subject9s motor threshold intensity. Each stimulation position received 10 trains separated by a 25-second pause. No clinically apparent mood changes were evoked by rTMS to any of the scalp positions …

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentmedia_common.quotation_subjectEmotionsHappinessPainPrefrontal CortexStimulationAudiologyAnxietybehavioral disciplines and activitiesFunctional LateralityReference ValuesCortex (anatomy)mental disordersmedicineHumansPrefrontal cortexmedia_commonTranscranial Magnetic StimulationFrontal LobeTranscranial magnetic stimulationSadnessAffectMoodmedicine.anatomical_structureOrgan SpecificityScalpLateralityFemaleNeurology (clinical)PsychologyNeurosciencepsychological phenomena and processesNeurology
researchProduct

The costs of social anxiety disorder: The role of symptom severity and comorbidities

2013

Abstract Background Social anxiety disorder (SAD) is associated with low direct costs compared to other anxiety disorders while indirect costs tend to be high. Mental comorbidities have been identified to increase costs, but the role of symptom severity is still vague. The objective of this study was to determine the costs of SAD, and to explore the impact of symptoms and comorbidities on direct and indirect costs. Methods Baseline data, collected within the SOPHO-NET multi-centre treatment study ( N =495), were used. Costs were calculated based on health care utilization and lost productivity. Symptom severity was measured with the Liebowitz-Social-Anxiety-Scale; comorbidities were include…

AdultMalemedicine.medical_specialtyTotal costPopulationComorbidityEfficiencySeverity of Illness IndexYoung Adult03 medical and health sciencesIndirect costs0302 clinical medicineCost of IllnessAbsenteeismmental disordersHealth caremedicineHumans030212 general & internal medicineSocial BehaviorPsychiatryeducationhealth care economics and organizationseducation.field_of_studybusiness.industrySocial anxietyMiddle Agedmedicine.diseaseAnxiety Disorders3. Good health030227 psychiatryPsychiatry and Mental healthClinical PsychologyEating disordersAbsenteeismAnxietyFemaleSelf Reportmedicine.symptomPsychologybusinessJournal of Affective Disorders
researchProduct

Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an associati…

2000

Polymorphisms in the serotonergic system are believed to play a role in the etiology and treatment of different psychiatric illnesses. The 5-HT2C receptor gene is X-linked, with a frequent mutation at nucleotide 68 leading to a Ser-->Cys transition at amino acid 23. Recent studies have demonstrated an impaired function of 5-HT2C receptors and an increased production of the major noradrenergic metabolite 3-methoxy-4-hydroxyphenylethyleneglycol in the cerebrospinal fluid among the subjects carrying the Ser23 allele (Lappalainen et al., 1999). Biol. Psychiatry 46:821). We genotyped patients with alcohol dependence, panic disorder without agoraphobia, generalized anxiety disorder, narcolepsy an…

AdultMalemedicine.medical_specialtyX ChromosomeGeneralized anxiety disorderGene FrequencyReference ValuesGenotypeReceptor Serotonin 5-HT2CSerineGeneticsmedicineHumansCysteineAllelePsychiatryAllele frequencyAllelesBiological PsychiatryGenetics (clinical)NarcolepsySex CharacteristicsPolymorphism Geneticbusiness.industryMental DisordersPanic disorderAlcohol dependenceMiddle Agedmedicine.diseaseAnxiety DisordersAlcoholismPsychiatry and Mental healthAmino Acid SubstitutionReceptors SerotoninPanic DisorderFemalebusinessAgoraphobiaNarcolepsyPsychiatric Genetics
researchProduct

The rates of co-occurring behavioural addictions in treatment-seeking individuals with obsessive-compulsive disorder: a preliminary report

2020

Objectives: To assess the rates of co-occurring putative ‘behavioural addictions’ in patients with obsessive-compulsive disorder (OCD). Methods: Twenty-three international centres specialising in the treatment of OCD were invited to participate in a survey of the rates of behavioural addictions and other relevant comorbidity within their samples. Results: Sixteen of 23 (69.6%) invited centres from 13 countries had sufficient data to participate in the survey. The use of validated diagnostic tools was discrepant, with most centres relying on a ‘clinical diagnosis’ to diagnose behavioural addictions. The final sample comprised of 6916 patients with a primary diagnosis of OCD. The reported rat…

AdultMalemedicine.medical_specialtybehavioural addictionsAdolescentSexual Behaviormedia_common.quotation_subjectDiagnosis; behavioural addictions; obsessive-compulsive disorderbehavioural addictionComorbidityDiagnostic toolsYoung Adult03 medical and health sciences0302 clinical medicineCo occurringObsessive compulsivePreliminary reportmental disordersDiagnosismedicineHumansPsychiatrymedia_commonTreatment seekingAddictionMiddle Agedmedicine.diseaseComorbidity030227 psychiatryBehavior Addictiveobsessive-compulsive disorderPsychiatry and Mental healthVideo Gamesbehavioural addictions; Diagnosis; obsessive-compulsive disorderClinical diagnosisGamblingFemalePsychologyInternet Addiction Disorder030217 neurology & neurosurgeryDiagnosi
researchProduct